🕒 Wednesday 22 July 2026 Wed, 22 July 2026

RocketDNA reported a 52% year-on-year revenue increase and expanded its autonomous drone operations with four new enterprise customers in Q2 FY26. The company also advanced software integration with Deswik to embed drone data into mine-planning workflows.

Rox Resources has secured full permits and major contracts to push forward construction at Youanmi, with mining and processing plant works advancing towards a mid-2027 gold pour.

Resolute Mining has lifted its ABC Project inferred gold resource to over 3 million ounces following extensive drilling, setting the stage for a $15-25 million feasibility push.

Galileo Mining has pinpointed a new drill target at its Norseman project, just 2km from the Callisto resource, following rock chip samples grading up to 1.87 g/t combined palladium, platinum and gold. An aircore drilling program is planned to test the untested mineralised zone beneath outcrop.

Entropy Neurodynamics has reported breakthrough Phase 2 clinical results for its intravenous psilocin therapy in treatment-resistant Binge Eating Disorder, alongside strong Phase 2a data in Irritable Bowel Syndrome and a new US patent filing.

Noxopharm reported significant progress in its Sofra technology, highlighting enhanced cancer drug potential and preparations for a US FDA clinical trial, while managing tight cash reserves.

Tali Resources (ASX: TR2) is gearing up for a major exploration push across its 4,000km2 West Arunta tenure, targeting copper and critical metals with multiple drilling programs scheduled throughout 2026.

Polymetals Resources continues to confirm substantial high-grade silver-lead-zinc mineralisation at the Endeavor Mine's upper Main Lode, progressing towards a new Mineral Resource estimate.

Optiscan Imaging has kicked off a US clinical trial with Mayo Clinic to test its InVue and InForm devices in breast conserving surgery, aiming to generate data for FDA 510(k) submissions and validate a new surgical-pathology workflow.

Aruma Resources has launched a 3,600m Phase 2 diamond drilling program at its Tillex Copper-Silver Project in Ontario’s Timmins district, targeting extensions of a high-grade mineralised system identified in Phase 1.

Mitchell Services reported a robust FY26 with EBITDA up 67% and a net cash position of $3.5 million, driven by a shift towards gold projects and rising rig activity.

Nordic Resources (ASX:NNL) has reported robust assay results from three final step-out drill holes at its Kopsa project in Finland, revealing over 100 metres of continuous gold-copper mineralisation well beyond previous boundaries. These findings suggest a meaningful expansion of the Kopsa resource, which currently holds 814,800oz AuEq.

Ardea Resources is pushing forward its Kalgoorlie Nickel Project’s Goongarrie Hub with a fully funded $98.5 million Definitive Feasibility Study, underpinned by multi-jurisdictional government support and strategic partnerships with Japanese industry giants.

Brookside Energy has successfully set and cemented intermediate casing at its Sabres well in Oklahoma’s Anadarko Basin, progressing into the lateral section and preparing for the next phase of drilling at the Suttles pad.

Battery Age Minerals has expanded its Falcon Lake lithium project in Ontario by staking 46 new mineral claims, boosting its district-scale footprint to 60 km² and reinforcing its position in a prolific lithium corridor with multi-element potential.

Radiopharm Theranostics reported robust Phase 2b results for RAD101 in brain metastases imaging, hitting 93% concordance with MRI and setting the stage for a U.S. Phase 3 trial. Meanwhile, its Phase 1 trial of RAD204 showed durable partial responses and good tolerability in advanced solid tumors.

Medallion Metals has signed a non-binding Term Sheet with TG Metals to process 60,000 tonnes of gold stockpiles at its Cosmic Boy Concentrator, sharing pre-tax profits equally after cost recovery. This deal complements Medallion’s Early Production Strategy and will not disrupt its Ravensthorpe project timeline.

Ariana Resources reports steady progress at its Tavşan gold mine in Türkiye with ramp-up completed and operational enhancements ongoing, while moving to simplify its Turkish portfolio by planning a sale of its Kiziltepe interest.

Novo Resources has validated a significant hydrothermal system at its Wyloo Polymetallic Project through maiden drilling and identified new IOCG-style targets at Toolunga, broadening its exploration pipeline in Western Australia.

Westgold Resources delivered a record 387,354oz gold production in FY26, exceeding guidance, while closing the year with a robust $939 million in cash and liquid assets, remaining debt free and unhedged.

Buru Energy pushes forward with its Rafael Gas Project development, securing A$5.3 million in funding and progressing environmental approvals while navigating executive leadership changes.

Coda Minerals has cleared a key regulatory hurdle for its Elizabeth Creek Copper-Silver Project with the formal gazettal of its Scoping Report, setting a clear pathway for mining lease approval and reducing project uncertainty.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its Phase 1b trial of PYC-003 for Polycystic Kidney Disease, alongside regulatory clearance for an Open-Label Extension allowing continuous dosing up to 24 months.

Maritana Minerals is pushing ahead with its Black Swan Processing Hub development, targeting 100,000 ounces of gold production by H2 2027, supported by a strong cash position of $229.5 million.